GQYR

United States Cancer Vaccines Market Report 2016 - Dendreon GlaxoSmithKline Merck Sanofi Vaccinogen Vaxon Biotech Vical Aduro BioTech

Press Release   •   Oct 03, 2016 15:07 IST

This report studies sales (consumption) of Cancer Vaccines in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Dendreon
GlaxoSmithKline
Merck
Sanofi
Vaccinogen
Vaxon Biotech
Vical
Aduro BioTech
Advantagene
Advaxis
Agenus
AlphaVax
Altor BioScience
Amgen
Antigen Express
Argos Therapeutics
Biothera
Bristol-Myers Squibb
Celldex Therapeutics

View Full Report With Complete TOC, List Of Figure and Table: http://globalqyresearch.com/united-states-cancer-vaccines-market-report-2016 

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I
Type II
Type III

Split by applications, this report focuses on sales, market share and growth rate of Cancer Vaccines in each application, can be divided into
Application 1
Application 2
Application 3

Download Sample this Report: http://globalqyresearch.com/download-sample/103939

Table of Contents

United States Cancer Vaccines Market Report 2016
1 Cancer Vaccines Overview
1.1 Product Overview and Scope of Cancer Vaccines
1.2 Classification of Cancer Vaccines
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Cancer Vaccines
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cancer Vaccines (2011-2021)
1.4.1 United States Cancer Vaccines Sales and Growth Rate (2011-2021)
1.4.2 United States Cancer Vaccines Revenue and Growth Rate (2011-2021)

2 United States Cancer Vaccines Competition by Manufacturers
2.1 United States Cancer Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cancer Vaccines Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cancer Vaccines Average Price by Manufactures (2015 and 2016)
2.4 Cancer Vaccines Market Competitive Situation and Trends
2.4.1 Cancer Vaccines Market Concentration Rate
2.4.2 Cancer Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Cancer Vaccines Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Cancer Vaccines Sales and Market Share by Type (2011-2016)
3.2 United States Cancer Vaccines Revenue and Market Share by Type (2011-2016)
3.3 United States Cancer Vaccines Price by Type (2011-2016)
3.4 United States Cancer Vaccines Sales Growth Rate by Type (2011-2016)

4 United States Cancer Vaccines Sales (Volume) by Application (2011-2016)
4.1 United States Cancer Vaccines Sales and Market Share by Application (2011-2016)
4.2 United States Cancer Vaccines Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States Cancer Vaccines Manufacturers Profiles/Analysis
5.1 Dendreon
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Cancer Vaccines Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Dendreon Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 GlaxoSmithKline
5.2.2 Cancer Vaccines Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 GlaxoSmithKline Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Merck
5.3.2 Cancer Vaccines Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Merck Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Sanofi
5.4.2 Cancer Vaccines Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Sanofi Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Vaccinogen
5.5.2 Cancer Vaccines Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Vaccinogen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Vaxon Biotech
5.6.2 Cancer Vaccines Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Vaxon Biotech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Vical
5.7.2 Cancer Vaccines Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Vical Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Aduro BioTech
5.8.2 Cancer Vaccines Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Aduro BioTech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Advantagene
5.9.2 Cancer Vaccines Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Advantagene Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Advaxis
5.10.2 Cancer Vaccines Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Advaxis Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Agenus
5.12 AlphaVax
5.13 Altor BioScience
5.14 Amgen
5.15 Antigen Express
5.16 Argos Therapeutics
5.17 Biothera
5.18 Bristol-Myers Squibb
5.19 Celldex Therapeutics

6 Cancer Vaccines Manufacturing Cost Analysis
6.1 Cancer Vaccines Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Cancer Vaccines

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Cancer Vaccines Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States Cancer Vaccines Market Forecast (2016-2021)
10.1 United States Cancer Vaccines Sales, Revenue Forecast (2016-2021)
10.2 United States Cancer Vaccines Sales Forecast by Type (2016-2021)
10.3 United States Cancer Vaccines Sales Forecast by Application (2016-2021)
10.4 Cancer Vaccines Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

To Purchase this Premium Report: http://globalqyresearch.com/checkout-form/0/103939

Why Global QY Research ?

Technically acclaimed Analysts with complete industry knowhow
Robust research methodology followed by our publishers to arrive at market estimates
Focus on technology trends
Extensive repository of market research reports to meet our client’s needs
Based on extensive research, we provide clear view of real market scenario and help clients with making informed business decisions

About Us:

Global QY Research is the one spot destination for all your research needs. Global QY Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Email: sales@globalqyresearch.com

Follow us: https://www.linkedin.com/company/global-qy-research